Influence of comorbidities on outcome in 1102 patients with an allogeneic hematopoietic stem cell transplantation

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT2005 · 2,979 citations
2. 2Body Mass Index, Abnormal Glucose Metabolism, and Mortality from Hematopoietic Cancer2006 · 76 citations
3. 3How much has allogeneic stem cell transplant–related mortality improved since the 1980s? A retrospective analysis from the EBMT2020 · 207 citations
4. 4A modified EBMT risk score and the hematopoietic cell transplantation-specific comorbidity index for pre-transplant risk assessment in adult acute lymphoblastic leukemia2009 · 69 citations
5. 5A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older2022 · 23 citations